CARL L. GORDON

Insider Reports History

Location
New York, NY
Signature
/s/ Carl L. Gordon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CARL L. GORDON:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Venetian-1 Acquisition Corp. Director Common Stock 2.68M $10.7M $4.00 01 Nov 2024 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 748K $8.11M $10.84 18 Feb 2025 Indirect
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 756K $7.56M $10.00 16 Jul 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Common Stock 1.51M $5.52M $3.65 30 Jan 2024 Indirect
Adicet Bio, Inc. Director, 10%+ Owner Common Stock 647K $925K $1.43 05 Jun 2024 Indirect
Keros Therapeutics, Inc. Director Common Stock 45.1K $800K $17.75 21 Nov 2025 Indirect
Adicet Bio, Inc. Director, 10%+ Owner Common Stock 11.8K $16.9K $1.43 05 Jun 2024 Direct
Compass Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $1.59 09 Apr 2025 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 0 $0 $2.59 03 Apr 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 0 $0 $3.05 14 Feb 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Restricted Stock Units 0 $0 $3.05 14 Feb 2024 Direct
Compass Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40K 11 Feb 2025 Direct
Adicet Bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 26.4K 21 Aug 2024 Direct
Gemini Therapeutics, Inc. /DE Director, 10%+ Owner Stock Option (Right to Buy) 17.2K 04 Oct 2021 Direct
Oric Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (right to buy) 16.6K 16 Jun 2021 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16K 12 Sep 2024 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10.5K 04 Jun 2025 Direct
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 4.68K 01 Jul 2024 Direct
ArriVent Biopharma, Inc. Director, 10%+ Owner Series A Preferred Stock 0 30 Jan 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series B Preferred Stock 0 30 Jan 2024 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Stock Option (right to buy) 0 03 Apr 2024 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series C Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Genesis Master Fund, L.P.
Venetian-1 Acquisition Corp. Director Simple Agreement for Future Equity 0 01 Nov 2024 Indirect

Insider Reports Filed by CARL L. GORDON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 21 Nov 2025 2 -$3.81M 4 Director 18 Dec 2025, 16:27
KROS Keros Therapeutics, Inc. 04 Jun 2025 2 $0 4 Director 06 Jun 2025, 16:15
CMPX Compass Therapeutics, Inc. 09 Apr 2025 1 -$5.68M 4 Director, 10%+ Owner 11 Apr 2025, 19:37
MBX MBX Biosciences, Inc. 14 Feb 2025 4 $2.02M 4 Director, 10%+ Owner 19 Feb 2025, 17:56
CMPX Compass Therapeutics, Inc. 11 Feb 2025 1 $0 4 Director, 10%+ Owner 13 Feb 2025, 17:08
NONE Lomond Therapeutics Holdings, Inc. 01 Nov 2024 13 $10M 4 Director 05 Nov 2024, 18:01
NONE Lomond Therapeutics Holdings, Inc. 01 Nov 2024 0 $0 3 Director 05 Nov 2024, 17:56
MBX MBX Biosciences, Inc. 16 Sep 2024 7 $12M 4 Director, 10%+ Owner 17 Sep 2024, 20:05
MBX MBX Biosciences, Inc. 12 Sep 2024 1 $0 4 Director, 10%+ Owner 13 Sep 2024, 17:19
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 Director, 10%+ Owner 12 Sep 2024, 19:15
ACET Adicet Bio, Inc. 21 Aug 2024 8 $0 4 Director, 10%+ Owner 23 Aug 2024, 16:08
KROS Keros Therapeutics, Inc. 13 Aug 2024 2 -$11M 4 Director 15 Aug 2024, 17:06
TERN Terns Pharmaceuticals, Inc. 15 Jul 2024 6 -$562K 4 Director, 10%+ Owner 17 Jul 2024, 20:53
TERN Terns Pharmaceuticals, Inc. 01 Jul 2024 1 $0 4 Director, 10%+ Owner 02 Jul 2024, 18:36
TERN Terns Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director, 10%+ Owner 14 Jun 2024, 18:04
ACET Adicet Bio, Inc. 05 Jun 2024 2 $0 4 Director, 10%+ Owner 07 Jun 2024, 16:08
KROS Keros Therapeutics, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:15
KNTE Kinnate Biopharma Inc. 03 Apr 2024 8 $0 4 Director, 10%+ Owner 05 Apr 2024, 16:39
THRX Theseus Pharmaceuticals, Inc. 14 Feb 2024 3 $0 4 Director, 10%+ Owner 14 Feb 2024, 16:01
CMPX Compass Therapeutics, Inc. 09 Feb 2024 1 $0 4 Director, 10%+ Owner 14 Feb 2024, 12:02
AVBP ArriVent Biopharma, Inc. 30 Jan 2024 10 $8M 4 Director, 10%+ Owner 31 Jan 2024, 16:11
ACET Adicet Bio, Inc. 25 Jan 2024 3 $7.5M 4 Director, 10%+ Owner 26 Jan 2024, 19:13
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 Director, 10%+ Owner 25 Jan 2024, 20:36
ACET Adicet Bio, Inc. 14 Aug 2023 8 $0 4 Director, 10%+ Owner 16 Aug 2023, 18:08
THRX Theseus Pharmaceuticals, Inc. 17 Jul 2023 2 $1.46M 4 Director, 10%+ Owner 19 Jul 2023, 16:17
ACET Adicet Bio, Inc. 27 Jun 2023 4 $1.83M 4 Director, 10%+ Owner 29 Jun 2023, 16:51
THRX Theseus Pharmaceuticals, Inc. 13 Jun 2023 2 $0 4 Director, 10%+ Owner 13 Jun 2023, 17:29
TERN Terns Pharmaceuticals, Inc. 12 Jun 2023 1 $0 4 Director, 10%+ Owner 14 Jun 2023, 19:01
KNTE Kinnate Biopharma Inc. 12 Jun 2023 1 $0 4 Director, 10%+ Owner 13 Jun 2023, 18:29
KROS Keros Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:48
ACET Adicet Bio, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 17:47
KNTE Kinnate Biopharma Inc. 04 May 2023 5 $4.09M 4 Director, 10%+ Owner 08 May 2023, 17:11
KNTE Kinnate Biopharma Inc. 28 Apr 2023 9 $3.67M 4 Director, 10%+ Owner 02 May 2023, 21:38
KNTE Kinnate Biopharma Inc. 17 Feb 2023 2 $0 4 Director, 10%+ Owner 22 Feb 2023, 15:30
CMPX Compass Therapeutics, Inc. 08 Feb 2023 1 $0 4 Director, 10%+ Owner 09 Feb 2023, 15:28
TERN Terns Pharmaceuticals, Inc. 23 Dec 2022 1 $1M 4 Director, 10%+ Owner 28 Dec 2022, 16:46
CMPX Compass Therapeutics, Inc. 08 Nov 2022 1 $1.29M 4 Director, 10%+ Owner 10 Nov 2022, 15:38
THRX Theseus Pharmaceuticals, Inc. 07 Nov 2022 1 $1M 4 Director, 10%+ Owner 09 Nov 2022, 15:29
TERN Terns Pharmaceuticals, Inc. 16 Aug 2022 6 $8.93M 4 Director, 10%+ Owner 18 Aug 2022, 16:50
TERN Terns Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director, 10%+ Owner 21 Jun 2022, 21:00
KNTE Kinnate Biopharma Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:00
THRX Theseus Pharmaceuticals, Inc. 10 Jun 2022 1 $0 4 Director, 10%+ Owner 13 Jun 2022, 20:10
ACET Adicet Bio, Inc. 02 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:42
KROS Keros Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:25
CMPX Compass Therapeutics, Inc. 11 May 2022 3 $420K 4 Director, 10%+ Owner 13 May 2022, 17:48
CMPX Compass Therapeutics, Inc. 06 May 2022 3 $197K 4 Director, 10%+ Owner 10 May 2022, 18:19
CMPX Compass Therapeutics, Inc. 18 Feb 2022 1 $0 4 Director, 10%+ Owner 23 Feb 2022, 16:45
KNTE Kinnate Biopharma Inc. 11 Feb 2022 4 $1.99M 4 Director 15 Feb 2022, 20:51
THRX Theseus Pharmaceuticals, Inc. 19 Jan 2022 3 $1.58M 4 Director, 10%+ Owner 21 Jan 2022, 18:22
THRX Theseus Pharmaceuticals, Inc. 11 Jan 2022 4 $443K 4 Director, 10%+ Owner 13 Jan 2022, 18:27
ACET Adicet Bio, Inc. 10 Dec 2021 1 $3M 4 Director, 10%+ Owner 14 Dec 2021, 18:06
CMPX Compass Therapeutics, Inc. 04 Nov 2021 2 $18.8M 4 Director, 10%+ Owner 08 Nov 2021, 20:12
THRX Theseus Pharmaceuticals, Inc. 12 Oct 2021 7 $10M 4 Director, 10%+ Owner 14 Oct 2021, 17:00
THRX Theseus Pharmaceuticals, Inc. 06 Oct 2021 1 $0 4 Director, 10%+ Owner 08 Oct 2021, 19:00
THRX Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 Director, 10%+ Owner 06 Oct 2021, 19:00
IRON Gemini Therapeutics, Inc. /DE 04 Oct 2021 1 $0 4 Director, 10%+ Owner 06 Oct 2021, 16:15
ORIC Oric Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director, 10%+ Owner 17 Jun 2021, 19:44
KROS Keros Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 17:27